For instance, Taylor et al. [39] examined the effect of GSK3 using GSK-3 siRNA or SB415286, in CD8(+) T cells, which was found to be involved in AD pathology [40], and they found a huge decrease in PD-1 expression. This evidence concerns the gene CD8A and Alzheimer disease.